Literature DB >> 24854843

Down-regulation of miR-3928 promoted osteosarcoma growth.

Haidong Xu1, Xiaozhou Liu, Jianning Zhao.   

Abstract

BACKGROUND: Osteosarcoma is the most common primary bone malignancy in children and young adults. Most failures of osteosarcoma treatment were due to resistance to chemotherapy. Development of new therapy required elucidation underlying molecular mechanism. Many miRNAs have been proved to be involved in the pathogenesis of osteosarcoma.
METHODS: MiR-3928 expression level was assayed by qRT-PCR. MiRNA mimics or ASO were transfected for up-regulation or down-regulation of miR-3928 expression. Cell proliferation was assayed by formazan test. Apoptosis and cell cycle were assayed by FACS. MiR-3928 targeted genes were predicated by bioinformatics algorithm (TargetScanHuman). The correlation between targeted gene and miR-3928 was analyzed by Pearson's correlation coefficient analysis.
RESULTS: MiR-3928 was down-regulated in osteosarcoma tissues. Over-expression of miR-3928 inhibited tumor growth, induced cell apoptosis, increased the percent of cells in G1 phrase and decreased the percent of cells in S phrase. Down-regulation of miR-3928 promoted cell proliferation. ERBB3, IL-6R and CDK6 may be the targeted genes of miR-3928.
CONCLUSIONS: Down-expression of miR-3928 in osteosarcoma promoted tumor growth by targeting ERBB3, IL-6R and CDK6. MiR-3928 may be a potential therapy target worth further investigation.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24854843     DOI: 10.1159/000358718

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  16 in total

1.  Enhanced Wnt signaling by methylation-mediated loss of SFRP2 promotes osteosarcoma cell invasion.

Authors:  Qiang Xiao; Yu Yang; Xuepu Zhang; Qing An
Journal:  Tumour Biol       Date:  2015-12-01

Review 2.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

Review 3.  Review of microRNA in osteosarcoma and chondrosarcoma.

Authors:  Le Chang; Swati Shrestha; Greg LaChaud; Michelle A Scott; Aaron W James
Journal:  Med Oncol       Date:  2015-04-26       Impact factor: 3.064

4.  Shikonin inhibits invasiveness of osteosarcoma through MMP13 suppression.

Authors:  Biyong Deng; Bing Qiu
Journal:  Tumour Biol       Date:  2015-06-24

5.  miR-574-3p acts as a tumor promoter in osteosarcoma by targeting SMAD4 signaling pathway.

Authors:  Haidong Xu; Xiaozhou Liu; Juan Zhou; Xiaoyun Chen; Jianning Zhao
Journal:  Oncol Lett       Date:  2016-11-07       Impact factor: 2.967

6.  Overexpression of miR-100 inhibits growth of osteosarcoma through FGFR3.

Authors:  Yunlong Bi; Yu Jing; Yang Cao
Journal:  Tumour Biol       Date:  2015-05-29

7.  MicroRNA-153 inhibits osteosarcoma cells proliferation and invasion by targeting TGF-β2.

Authors:  Guangfeng Niu; Bin Li; Li Sun; Chenggong An
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

8.  MicroRNA-610 suppresses osteosarcoma oncogenicity via targeting TWIST1 expression.

Authors:  Chi Jin; Yongjian Feng; Yongjian Ni; Zhonglin Shan
Journal:  Oncotarget       Date:  2017-04-11

9.  Mesenchymal Stem/Stromal Cells under Stress Increase Osteosarcoma Migration and Apoptosis Resistance via Extracellular Vesicle Mediated Communication.

Authors:  Krishna C Vallabhaneni; Meeves-Yoni Hassler; Anu Abraham; Jason Whitt; Yin-Yuan Mo; Azeddine Atfi; Radhika Pochampally
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

10.  Prognostic significance of the expression of HER family members in primary osteosarcoma.

Authors:  Sheng-Lin Wang; Guang-Xian Zhong; Xin-Wen Wang; Feng-Qiang Yu; Dan-Feng Weng; Xin-Xing Wang; Jian-Hua Lin
Journal:  Oncol Lett       Date:  2018-06-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.